Results 81 to 90 of about 18,455 (220)
Apparent pacemaker dysfunction during peptide receptor radionuclide therapy for neuroendocrine tumor
Key Clinical Message This case is a reminder not to overlook rare causes of electrolyte shifts, which may cause reversible changes in pacemaker pacing thresholds.
Stefan Asbach +4 more
doaj +1 more source
Paraganglioma of the thyroid gland: A case report [PDF]
Introduction. Thyroid paraganglioma is a very rare malignant neuroendocrine tumor. Immunohistochemical features of thyroid paraganglioma are helpful for the diagnosis. Case report.
Filipović Aleksandar +2 more
doaj +1 more source
Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount [PDF]
Background: Targeted radionuclide therapy with high-energy beta-emitters is generally considered suboptimal to cure small tumours (90Y, 177Lu or 213Bi, accounting for the radionuclide specific activities (SAs), the tumour absorbed doses and tumour (radio)
Blois, E. (Erik) de +8 more
core +2 more sources
Peptide Receptor Radionuclide Therapy in the United States [PDF]
TO THE EDITOR: We read with great interest the article by Drs. Graham and Menda titled “Radiopeptide Imaging and Therapy in the United States” published in the recent supplement to The Journal of Nuclear Medicine ([1][1]).
Peeyush, Bhargava, Ebrahim S, Delpassand
openaire +2 more sources
Ultrasmall Au10–12 Nanoclusters: A Novel Platform for 223Ra‐Targeted Tumor α‐Therapy
Encapsulating 223Ra in Au10‐12 nanoclusters and functionalizing them with RGD peptides enables targeted α‐therapy and immune microenvironment remodeling in non‐osseous tumors like triple‐negative breast cancer. This study establishes a foundational framework for novel 223Ra‐labeled α‐radiopharmaceuticals and shows strong potential for clinical ...
Yifei Jiang +11 more
wiley +1 more source
Molecular theranostics: principles, challenges and controversies
Molecular theranostics offers a powerful tool to drive precision medicine in nuclear oncology. While theranostics is not a new principle in nuclear medicine, recent advances in instrumentation and radiopharmacy have driven a reinvigoration and a broader suite of applications.
Geoffrey Currie
wiley +1 more source
Vascular endothelial growth factor receptor (VEGFR) is a critical factor in tumor angiogenesis and has been considered a potential target for receptor-mediated radionuclide imaging and therapy.
Xiang Zhang +7 more
doaj +1 more source
A novel radio guided surgery (RGS) technique for cerebral tumors using $\beta^{-}$ radiation is being developed. Checking the availability of a radio-tracer that can deliver a $\beta^{-}$ emitter to the tumor is a fundamental step in the deployment of ...
BELLINI, Fabio +23 more
core +1 more source
Analysis of iodinated quorum sensing peptides by LC-UV/ESI ion trap mass spectrometry [PDF]
Five different quorum sensing peptides (QSP) were iodinated using different iodination techniques. These iodinated peptides were analyzed using a C-18 reversed phase HPLC system, applying a linear gradient of water and acetonitrile containing 0.1% (m/v ...
De Spiegeleer, Bart +5 more
core +2 more sources
Cutting‐edge advances in bicyclic peptide‐based radiotracers for cancer imaging and theranostics
Abstract Along with successful clinical approval of radiopharmaceuticals targeting somatostatin receptor subtype 2 and prostate‐specific membrane antigen, peptide‐based radiotracers have garnered the increasing attention in cancer imaging and theranostics. As a newly emerging targeting ligand in recent years, bicyclic peptides have demonstrated immense
Hengyi Ou, Xiaobo Wang, Fei Kang
wiley +1 more source

